Ponec M, de Haas C, Bachra B N, Polano M K
Arch Dermatol Res (1975). 1977 Aug 22;259(2):117-23. doi: 10.1007/BF00557951.
Various glucocorticosteroids were added to logarithmically growing cultures of primary human skin fibroblasts and of mouse L929 fibroblasts. These steroids inhibited proliferation of the human fibroblasts at concentrations which fall in a range expected to occur during the topical treatment of skin disorders. In terms of the concentrations required for the inhibition hydrocortisone was least and clobetasol-17-propionate most effective. All other steroids studied (hydrocortisone-17-butyrate, triamcinolone acetonide, betamethasone-17-valerate and hydrocortisone-21-acetate) showed medium effectiveness. Fluorination as such may not enhance the inhibitory effect. The inhibition was independent of the source (baby foreskin or adult arm skin) and passage number (7th to 13th or 15th and 16th passage, respectively) of the cells. The possible relationship between the inhibition of cell proliferation by such steroids and their therapeutic effect in psoriasis and their atrophic side effects is discussed. Mouse L929 fibroblasts were affected at 10(3)--10(4)-fold lower steroid concentrations and the range of the effective concentrations was 10(4)--10(5) times as wide as that for the primary human skin fibroblasts. It was concluded that these mouse fibroblasts are a poor model system for the study of in vivo effects of glucocorticosteroids in man.
将各种糖皮质激素添加到原代人皮肤成纤维细胞和小鼠L929成纤维细胞的对数生长期培养物中。这些类固醇在皮肤疾病局部治疗预期出现的浓度范围内抑制人成纤维细胞的增殖。就抑制所需浓度而言,氢化可的松作用最小,丙酸氯倍他索最有效。所研究的所有其他类固醇(丁酸氢化可的松、曲安奈德、倍他米松戊酸酯和醋酸氢化可的松)显示出中等效力。单纯的氟化可能不会增强抑制作用。这种抑制作用与细胞来源(婴儿包皮或成人手臂皮肤)和传代次数(分别为第7至13代或第15和16代)无关。讨论了此类类固醇对细胞增殖的抑制作用与其在银屑病中的治疗效果及其萎缩性副作用之间的可能关系。小鼠L929成纤维细胞在低10³ - 10⁴倍的类固醇浓度下受到影响,有效浓度范围比原代人皮肤成纤维细胞宽10⁴ - 10⁵倍。得出的结论是,这些小鼠成纤维细胞是研究糖皮质激素在人体内体内效应的较差模型系统。